⌘K

Login Start Free

Home/Filings/4/0001213900-24-020088

4//SEC Filing

HULL ANDREW 4

Accession 0001213900-24-020088

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 3:20 PM ET

Size

5.5 KB

Accession

0001213900-24-020088

Insider Transaction Report

Form 4

Period: 2024-01-14

InMed Pharmaceuticals Inc.INM

Director

Transactions

Expiration (Short)
Employee Stock Option (Expiration)
2024-01-14−42→ 8,542 total
Exercise: $307.01From: 2019-01-14Exp: 2024-01-14→ Common shares (42 underlying)

Footnotes (1)

[F1]Converted from the Canadian dollar exercise price of C$412.50 using an exchange rate of C$1.3436 = $US1.00

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001818252

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 3:20 PM ET
Size: 5.5 KB

View on SEC.gov